Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase NA 1

Status

Recruiting 3

Sponsor Class

OTHER 24NIH 16NETWORK 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Leukemia, Biphenotypic, Acute 6Leukemia, Myeloid, Acute 5Carcinoma, Non-Small-Cell Lung 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Lung Neoplasms 4Burkitt Lymphoma 4Wilms Tumor 3Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 3Pancreatic Neoplasms 3Osteosarcoma 3Neuroblastoma 3Ganglioneuroblastoma 3Teratoma 2Sarcoma, Ewing 2Rhabdomyosarcoma 2Prostatic Neoplasms 2Melanoma 2Medulloblastoma 2Lymphoma, Non-Hodgkin 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma 2Hepatoblastoma 2Hematologic Neoplasms 2Fibrolamellar hepatocellular carcinoma 2Desmoid Tumors 2Carcinoma, Embryonal 2Anatomic Stage I Breast Cancer AJCC v8 2Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1

Interventions

Gemcitabine 17Fluorouracil 8Capecitabine 6Radiotherapy 5Leucovorin 5Albumin-Bound Paclitaxel 5Taxes 4Irinotecan 4Cisplatin 4130-nm albumin-bound paclitaxel 4Specimen Handling 3Radiotherapy, Conformal 3Docetaxel 3irinotecan sucrosofate 2dehydroftorafur 2Surgical Procedures, Operative 2Radiosurgery 2Pancreaticoduodenectomy 2Chemotherapy, Adjuvant 2Cetuximab 2trametinib 1tipifarnib 1saracatinib 1pegfilgrastim 1lanreotide 1ganitumab 1durvalumab 1conatumumab 1beta-D-glucosylisophosphoramide mustard 1Watchful Waiting 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
NETWORK × Pancreatic Neoplasms × Specimen Handling × Clear all
NCT04239573 2026-05-27

Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers

Eastern Cooperative Oncology Group

Phase NA Recruiting
770 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT06998940 2026-05-22

Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations

SWOG Cancer Research Network

Phase 3 Recruiting
94 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT06807437 2026-03-31

Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula

SWOG Cancer Research Network

Phase 3 Recruiting
274 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡